Novo Nordisk, the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Hims, Keeps and other companies advertise topical finasteride with limited disclosures of side effects.

The pharmaceutical company announced it would be partnering with Hims & Hers., LifeMD and Ro. to provide all five dose strengths of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499.

Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...

As part of its deal with Novo, Hims, along with LifeMD Inc., and Ro will sell a month’s supply of Wegovy starting at $499, a 63 percent discount, before subscription fees. Lilly also announced ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Ro teams up with Eli Lilly to offer single-dose vials of weight loss drug Zepbound Hims & Hers and Novo also said the two companies are collaborating beyond the Wegovy partnership but didn't ...

Rising Competition: Hims & Hers operates in a competitive digital health landscape, facing rivals like Teladoc, Ro and Amazon Pharmacy. These competitors leverage similar direct-to-consumer models ...

Novo Nordisk launched access to its popular weight loss GLP-1 drug, Wegovy, through multiple telehealth platforms, including ...

Hims & Hers Health announced on Tuesday it will ... Two other telehealth companies, Ro and Life MD, similarly unveiled partnerships with Novo Nordisk on Tuesday that will involve integrating ...